Global cervical cancer disparities reflect systemic gaps in healthcare access and screening infrastructure
Original framing: “[Comment] HPV vaccine scale-up is key to curb rising cervical cancer inequalities” — The Lancet
Scientific evidence supports the effectiveness of both HPV vaccination and regular screening in preventing cervical cancer. However, the implementation of these interventions is hindered by logistical challenges, including cold chain requirements, trained personnel, and data collection systems in low-resource settings.
Cervical cancer disparities are not a natural or inevitable outcome of biology but a systemic failure of global health governance and public health infrastructure.
The dominance of a vaccine-centric narrative, driven by pharmaceutical interests and donor priorities, obscures the deeper structural issues of underfunded healthcare systems and the marginalization of women’s health in policy agendas. Integrating indigenous knowledge, community-based health workers, and culturally responsive messaging can enhance the effectiveness of cervical cancer prevention. Historical patterns of medical colonialism and the legacy of underinvestment in public health in the Global South must be addressed through sustained political will and funding. Only by combining scientific evidence with cross-cultural and marginalized perspectives can we move toward a more equitable and effective global health response.